Spero Therapeutics
SPRO
SPRO
84 hedge funds and large institutions have $316M invested in Spero Therapeutics in 2021 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 25 increasing their positions, 20 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
3% less funds holding
Funds holding: 87 → 84 (-3)
6% less capital invested
Capital invested by funds: $338M → $316M (-$21.8M)
23% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 13
Holders
84
Holding in Top 10
2
Calls
$1.1M
Puts
$711K
Top Buyers
| 1 | +$6.41M | |
| 2 | +$943K | |
| 3 | +$666K | |
| 4 |
State Street
Boston,
Massachusetts
|
+$661K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$567K |
Top Sellers
| 1 | -$3.58M | |
| 2 | -$2.83M | |
| 3 | -$1.07M | |
| 4 |
WJWM
Williams Jones Wealth Management
New York
|
-$488K |
| 5 |
CCIA
Campbell & Co Investment Adviser
Baltimore,
Maryland
|
-$440K |